Literature DB >> 9367684

Complex expression pattern of the TNF region gene LST1 through differential regulation, initiation, and alternative splicing.

A de Baey1, B Fellerhoff, S Maier, S Martinozzi, U Weidle, E H Weiss.   

Abstract

Recently, a novel gene, LST1, was identified in the tumor necrosis factor region of the HLA complex, 4 kb centromeric of the lymphotoxin beta gene. By analyzing several full-length cDNA clones and the genomic DNA, we identified seven exons and four introns, spanning 2.7 kb. Isolation of mouse LST1 cDNA clones established the open reading frame. LST1 transcription is characterized by four alternative transcription initiation sites and extensive alternative splicing. The derived polypeptides vary with regard to the presence of the hydrophobic N-terminus and in short internal sequences. In addition, alternative splicing results in LST1 mRNAs encoding different carboxy-terminal sequences. LST1 is predominantly transcribed in monocytes, and mRNA levels increase upon stimulation with interferon-gamma, with a concomitant change in the mRNA pattern resulting in an enhanced expression of the short LST1 transcripts. These data suggest that LST1 may have a specific role in monocytes and possibly also in T cells. Moreover, we found that the recently published cDNA 1C7 is encoded just centromeric of LST1. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9367684     DOI: 10.1006/geno.1997.4963

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse.

Authors:  Tao Xie; Lee Rowen; Begoña Aguado; Mary Ellen Ahearn; Anup Madan; Shizhen Qin; R Duncan Campbell; Leroy Hood
Journal:  Genome Res       Date:  2003-12       Impact factor: 9.043

2.  LST1/A is a myeloid leukocyte-specific transmembrane adaptor protein recruiting protein tyrosine phosphatases SHP-1 and SHP-2 to the plasma membrane.

Authors:  Peter Draber; Ondrej Stepanek; Matous Hrdinka; Ales Drobek; Lukas Chmatal; Linda Mala; Tereza Ormsby; Pavla Angelisova; Vaclav Horejsi; Tomas Brdicka
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

3.  LST1 and NCR3 expression in autoimmune inflammation and in response to IFN-gamma, LPS and microbial infection.

Authors:  H Mulcahy; K P O'Rourke; C Adams; M G Molloy; F O'Gara
Journal:  Immunogenetics       Date:  2005-12-17       Impact factor: 2.846

4.  Identification of splicing silencers and enhancers in sense Alus: a role for pseudoacceptors in splice site repression.

Authors:  Haixin Lei; Igor Vorechovsky
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

5.  Regulation of Inflammatory Response by Transmembrane Adaptor Protein LST1.

Authors:  Matej Fabisik; Jolana Tureckova; Nataliia Pavliuchenko; Jarmila Kralova; Jana Balounova; Kristina Vicikova; Tereza Skopcova; Frantisek Spoutil; Jana Pokorna; Pavla Angelisova; Bernard Malissen; Jan Prochazka; Radislav Sedlacek; Tomas Brdicka
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

6.  An alternative downstream translation start site in the non-TIR adaptor Scimp enables selective amplification of CpG DNA responses in mouse macrophages.

Authors:  James Eb Curson; Lin Luo; Liping Liu; Belinda J Burgess; Nilesh J Bokil; Adam A Wall; Tomas Brdicka; Ronan Kapetanovic; Jennifer L Stow; Matthew J Sweet
Journal:  Immunol Cell Biol       Date:  2022-03-22       Impact factor: 5.853

7.  An upstream open reading frame regulates LST1 expression during monocyte differentiation.

Authors:  Christian Schiller; Carina Nowak; Kalliope N Diakopoulos; Ulrich H Weidle; Elisabeth H Weiss
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

8.  Lst1 deficiency has a minor impact on course and outcome of the host response to influenza A H1N1 infections in mice.

Authors:  Sarah R Leist; Heike Kollmus; Bastian Hatesuer; Ruth L O Lambertz; Klaus Schughart
Journal:  Virol J       Date:  2016-01-27       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.